🔎 Trials Near Me

Hem › Burkitts lymfom › Texas › San Antonio

Kliniska studier för Burkitts lymfom i San Antonio, TX

7 studier för Burkitts lymfom söker deltagare vid platser i och runt San Antonio (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2
  • Children's Hospital of San Antonio, San Antonio
  • Methodist Children's Hospital of South Texas, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
366 Days – 46 Years · Alla kön · Uppdaterad 2 okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2
  • Children's Hospital of San Antonio, San Antonio
  • Methodist Children's Hospital of South Texas, San Antonio
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2
  • Children's Hospital of San Antonio, San Antonio
  • Methodist Children's Hospital of South Texas, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Ålder 1 till 30 · Alla kön · Uppdaterad 1 sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3
  • Children's Hospital of San Antonio, San Antonio
  • Methodist Children's Hospital of South Texas, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

RekryterarFas 1/2
  • Sarah Cannon - Texas Transplant Institute at Methodist Hospital, San Antonio
Ålder 15 till 50 · Alla kön · Uppdaterad 9 sep. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RekryterarFas 2
  • Methodist Healthcare System, San Antonio
Ålder 1 till 25 · Alla kön · Uppdaterad 4 maj 2025 · NCT03509961

Burkitts lymfom-studier i andra städer

Andra studier i San Antonio

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.